EUVIMEDTutustu EUVIMEDiin
Crossref

Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF ‐1α/ HK2 pathway

Wenyu Hui, Wei Huang, Zuguo Zheng, Yi Li, Ping Li iD, Hua Yang iD

Phytotherapy Research · 2023-12 · 37 (12) · 5821-5836

DOI: 10.1002/ptr.7988 ↗

At a glance

Journal article in Phytotherapy Research, 2023-09. Written by Wenyu Hui and 5 co-authors. Institution: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Major MEDLINE topics: Ginkgo biloba, Ischemic Stroke. Cited 28 times so far (Crossref); 43 references. Funded by: Key R&D project of Shandong Province, National Natural Science Foundation of China.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

The ischemic brain can dialogue with peripheral tissues through the immune system. Ginkgo biloba extract (EGb) was used to regulate various neurological disorders; however, the impact of EGb on ischemic stroke is still unclear. Here, we aimed to investigate whether immunomodulation has participated in the beneficial effects of EGb on ischemia/reperfusion (I/R) brain injury. Mice were orally administered with EGb once daily for 7 days before the induction of I/R. Neurobehavioral scores, infarct volume, and brain inflammation were determined. The proportion of CD4 + T cells was detected by flow cytometry. EGb significantly lowered neurobehavioral scores, infarct volume, and the level of inflammatory cytokines in I/R mice. Interestingly, EGb altered the proportion of CD4 + T cells, particularly increasing the proportion of Treg cells. Depletion of Treg cells weakened the neuroprotective effects of EGb on ischemic stroke; furthermore, EGb decreased the expression of HIF‐1α and HK2 and promoted the differentiation of Treg cells in vitro. EGb suppressed the HIF‐1α/HK2 signaling pathway to promote the differentiation of Treg cells and ameliorate ischemic stroke in mice. The expansion effect of EGb on Treg cells could be exploited as part of future stroke therapy.

Subjects

MeSH terms (MEDLINE)

Ginkgo bilobaIschemic StrokeMiceAnimalsT-Lymphocytes, RegulatoryPlant ExtractsInfarctionGinkgo Extract

Author keywords

Ginkgo biloba extractHIF-1α/HK2Treg cellsglycolysisischemic stroke

Substances

Plant ExtractsGinkgo biloba extractGinkgo Extract

Authors and institutions

  • State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.

ORCID profiles: Ping Li, Hua Yang

Funding

  • Key R&D project of Shandong Province
  • National Natural Science Foundation of China

Cite

APA

Hui, W., Huang, W., Zheng, Z., Li, Y., Li, P., & Yang, H. (2023). Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF ‐1α/ HK2 pathway. Phytotherapy Research, 37(12), 5821-5836. https://doi.org/10.1002/ptr.7988

Vancouver

Hui W, Huang W, Zheng Z, Li Y, Li P, Yang H. Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF ‐1α/ HK2 pathway. Phytotherapy Research. 2023;37(12):5821-5836. doi:10.1002/ptr.7988

BibTeX
@article{Hui2023,
  author = {Hui, Wenyu and Huang, Wei and Zheng, Zuguo and Li, Yi and Li, Ping and Yang, Hua},
  title = {Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF ‐1α/ HK2 pathway},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {12},
  pages = {5821--5836},
  doi = {10.1002/ptr.7988}
}
Start for free →